Ansa Biotechnologies

Enabling the next generation of DNA synthesis using enzymes.

You can also find us at @ansabio.bsky.social

[Ansa Biotechnologies @AnsaBio]

Ansa Biotechnologies thanks all who have served in the US armed forces.

[Ansa Biotechnologies @AnsaBio]

Download our eBook, DNA Synthesis for the AI Era. This comprehensive guide explores how enzymatic DNA synthesis is changing reliability, sequence complexity, and speed. #DNASynthesis #EnzymaticDNASynthesis #AI https://t.co/TG8r9vXXfA

[Ansa Biotechnologies @AnsaBio]

We're hiring for multiple open roles! View the job postings: https://t.co/5qzjaqDlch!

[Ansa Biotechnologies @AnsaBio]

Whole Plasmid Synthesis is now in Early Access. Submit your plasmid map, we write the whole construct. Unlike other providers, we synthesize from scratch, so no physical DNA is needed. You define the construct: https://t.co/mkeAMhCjgH

[Ansa Biotechnologies @AnsaBio]

What makes a DNA sequence hard to synthesize? Two constructs of identical length can take very different paths through a manufacturing workflow. Read the DNA Synthesis 101 blog: #DNASynthesis #DNASynthesis101 https://t.co/mT3MxaIUdR

[Ansa Biotechnologies @AnsaBio]

Announcing Early Access orders for Whole Plasmid Synthesis at Ansa. We synthesize, assemble, and verify your full plasmid, including complex GC-rich and repetitive sequences. See the full details and get started with Early Access: https://t.co/fPb6vMSWEM

[Ansa Biotechnologies @AnsaBio]

Happy Ansaween! 🎃 😱 👻

[Ansa Biotechnologies @AnsaBio]

The Ansa Team celebrated Oktoberfest!

A special thanks to Matthias Arenskötter for the homemade German food. The spread included bratwurst, Leberkäse, spaetzle, sauerkraut, red cabbage, pretzels, and fresh bread, plus vegan sausages.

#Oktoberfest #TeamEvent #Bratwurst #Spaetzle

[Ansa Biotechnologies @AnsaBio]

Meet with the Ansa team at ESGCT, October 27-30, 2026, and see how our DNA synthesis platform can support your gene and cell therapy research.

📍 Find us at Booth C-08 at the Congress Center Hamburg. Schedule time: https://t.co/vJ718CtCAj

[Ansa Biotechnologies @AnsaBio]

Daniel Lin-Arlow noticed that DNA writing had barely changed in a decade, so he helped build a company to fix it.

https://t.co/ipOqHlW116

[Ansa Biotechnologies @AnsaBio]

Great conversations at ELRIG Drug Discovery this week where we presented a poster in collaboration with Axio Biopharma.
Missed us at the meeting?
Download the poster: https://t.co/YTkCiWhISu

[Ansa Biotechnologies @AnsaBio]

More DNA. Less bench work.

Announcing DNA SCALE-UP, a new product add-on for Clonal DNA and XL Clonal DNA orders.

Get consistent, high-purity DNA from the same verified clone, w/o re-culturing & re-prepping.

🧪https://t.co/DOmfGxe7rW

[Integrated DNA Technologies @idtdna]

Avoid dead-end workflows when your fragment request hits a limit. With IDT and @AnsaBio, there’s a better path forward. ⏩ Our “No Loose Ends” workflow helps guide complex designs beyond fragment fit—toward fully assembled clonal genes, without losing momentum. 🧬

So when your project gets more ambitious, your workflow doesn’t stall.

Learn more here: https://t.co/I9oY1jlbKe

[Ansa Biotechnologies @AnsaBio]

𝗔𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗔𝗦𝗛𝗚 𝟮𝟬𝟮𝟲 𝗶𝗻 𝗠𝗼𝗻𝘁𝗿𝗲𝗮𝗹? 𝗟𝗲𝘁’𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁! 🧬
Schedule time to meet with the Ansa team and explore how our enzymatic DNA synthesis platform can help advance your research.
👉Schedule time to meet: https://t.co/bpuMlfkR3g

[Ansa Biotechnologies @AnsaBio]

Two biosecurity wins! CA enacted gene synthesis screening requirements, and Ansa joined the International Gene Synthesis Consortium.
➡️ AB 1864: https://t.co/tVhfCIPQYI
➡️ IGSC: https://t.co/Pc697lWe67

[Ansa Biotechnologies @AnsaBio]

Every company has an origin story. Ours starts with a paper, a polymerase, and a lot of frustration with the DNA our founders couldn't buy. 🧬

Let's revisit where it all began: https://t.co/g17KPsCmvx

[Integrated DNA Technologies @idtdna]

400 institutions served. Up to 50kb. 97% fulfillment. 42x increase in complexity. IDT+@AnsaBio is a partnership that pushes beyond the traditional 7kb synthesis ceiling, and resets standards. Get greater design freedom here: https://t.co/XnnNNHV5nd

[Ansa Biotechnologies @AnsaBio]

Case Study: https://t.co/hyaYcUvgM2
The best-expressing antibody DNA is often what vendors call "complex."
With @AxioBiopharma, we tested 21 AI codon-optimized mAbs:
Vendor X: 11 rejected, 10 flagged complex
Ansa: 21/21 standard
In CHO: higher titers for 19/21, avg 1.9x

[Ansa Biotechnologies @AnsaBio]

At Ansa, pushing the boundaries of DNA synthesis goes hand in hand with responsible innovation.

Our SVP of Informatics, Scott Fay, spoke to @GenomeWeb about the industry’s responsibility to advance #AI & #DNAsynthesis technologies safely.

https://t.co/EzZKtaK40a

#biosecurity

[Ansa Biotechnologies @AnsaBio]

"Hard to synthesize" is almost never a synthesis problem.

Repeats, GC extremes, and homopolymers each fail at particular steps of a DNA manufacturing workflow — and not at the others.

Learn what makes DNA sequences hard to synthesize in our new article: https://t.co/d2yd1DFA8V